eXoZymes (NASDAQ:EXOZ) Trading Up 0.4% – What’s Next?

by · The Cerbat Gem

eXoZymes Inc. (NASDAQ:EXOZ – Get Free Report) shares were up 0.4% during trading on Thursday . The company traded as high as $13.48 and last traded at $12.20. Approximately 11,195 shares traded hands during mid-day trading, an increase of 288% from the average daily volume of 2,883 shares. The stock had previously closed at $12.15.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of eXoZymes in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on EXOZ

eXoZymes Stock Performance

The firm has a fifty day simple moving average of $14.10 and a 200-day simple moving average of $12.29. The company has a quick ratio of 4.53, a current ratio of 4.53 and a debt-to-equity ratio of 0.01. The company has a market cap of $103.20 million and a PE ratio of -15.97.

eXoZymes (NASDAQ:EXOZ – Get Free Report) last announced its earnings results on Thursday, November 13th. The company reported ($0.27) earnings per share (EPS) for the quarter.

eXoZymes Company Profile

(Get Free Report)

eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company’s enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.

Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.

eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.

Featured Stories